• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Apollo Consolidated Ltd

+ Add to Watchlist


0.0550 AUD 0.0020 3.51%

As of 01:35:40 ET on 07/03/2014.

Snapshot for Apollo Consolidated Ltd (AOP)

Open: 0.0600 Day's Range: 0.0550 - 0.0600 Volume: 20,000
Previous Close: 0.0570 52wk Range: 0.0259 - 0.0800 1-Yr Rtn: -

Stock Chart for AOP

No chart data available.
  • AOP:AU 0.0550
  • 1D
  • 1M
  • 1Y
Interactive AOP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AOP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0134
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 3.50
Shares Outstanding (M) 63.63
30 Day Average Volume 28,173
Price/Book (mrq) 0.6490
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AOP

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for AOP

Apollo Consolidated Ltd. is a biopharmaceutical company that creates, manufactures, and markets therapeutics based on human proteins, to protect and improve human health. The Company is developing treatments for a range of inflammatory, autoimmune, and neurological diseases, targeting the therapeutics, anti-aging/cosmetics, and research and development reagents markets.

Nicholas Castleden "Nick"Managing DirectorAlex J NeulingSecretary
More Company Profile & Key Executives for AOP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil